Clinical Trial Update: A Study to Evaluate the Long-Term Safety and Efficacy of JNT-517 in Participants With Phenylketonuria [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study to evaluate the long-term safety and efficacy of JNT-517 in participants with phenylketonuria, which is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• JNT-517

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Phenylketonuria (PKU) | Phase 3 | Status: RECRUITING